|
|
|
LifeScienceHistory.com - Check us out on Instagram
Take Your Next Career Step with Lundback
California Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing CaliforniaLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Codexis, Inc.
| | | Phone: | (650) 421-8100 | Fax: | (650) 2985449 | Year Established: | 2002 | Ticker: | CDXS | Exchange: | NASDAQ | Main Contact: | Michael Aldridge, Senior VP, Corporate & Strategic Development | | Other Contacts: | Jim Lalonde, Senior VP, R&D Douglas Sheehy, J.D., Executive VP, Chief Administrative Officer & General Counsel Gordon Sangster, Senior VP & CFO John Nicols, President & CEO
| | Company Description | Codexis is a privately held biotechnology company applying proprietary synthetic chemistry technologies to create improved versions of small molecule therapeutics. Codexis' technology enables novel process development solutions for efficient, cost-effective and environmentally friendly pharmaceutical manufacturing. Application of the company's proprietary protein and strain engineering platform can also generate new intellectual property opportunities for pharmaceutical manufacturers, which may extend the drug product lifecycle. Codexis has more than 15 strategic alliances, and the company's technology is being applied to the development of more than 20 therapeutic products worldwide. | |
|
|
|
|
|